Tag: CT-P13

Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease

Quick Take: Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn’s disease: an international, randomised, double-blind, phase 3 non-inferiority study

byDonna Leetand1 others

April 5, 2019

Anti-tumor necrosis factor (TNF) therapies are commonly used in the treatment of patients with moderate to severe Crohn’s disease. However, ...

Anti-TNF therapy for inflammatory bowel disease may induce skin lesions

2 Minute Medicine Rewind April 1, 2019

byDonna Leetand1 others

April 9, 2019

Outcomes of Extremely Preterm Infants With Birth Weight Less Than 400 g Little is known about the survival and neurodevelopmental ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result